Showing results (21-30 of 92) with videos related to
Sort By:
Pageof 10
Oncology|September 29, 2004
Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathyFrancesco Parmeggiani, Ciro Costagliola, Sergio D'Angelo, et al.Experimental Eye Research|June 14, 2005
The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patientsCiro Costagliola, Francesco Parmeggiani, Paolo Pio Antinozzi, et al.Plos One|October 27, 2017
Torsional phacoemulsification: A pilot study to revise the "harm scale" evaluating the endothelial damage and the visual acuity after cataract surgeryFrancesco Saverio Sorrentino, Silvia Matteini, Aurelio Imburgia, et al.American Journal of Ophthalmology|December 10, 2002
Recurrent episodes of spontaneous subconjunctival hemorrhage in patients with factor XIII Val34Leu mutationCarlo Incorvaia, Ciro Costagliola, Francesco Parmeggiani, et al.Expert Opinion on Pharmacotherapy|October 31, 2009
Pharmacotherapy of intraocular pressure: part I. Parasympathomimetic, sympathomimetic and sympatholyticsCiro Costagliola, Roberto dell'Omo, Mario R Romano, et al.Expert Opinion on Pharmacotherapy|November 26, 2009
Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamidesCiro Costagliola, Roberto dell'Omo, Mario R Romano, et al.Current Eye Research|June 24, 2008
Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprostCiro Costagliola, Claudio Campa, Paolo Perri, et al.European Journal of Ophthalmology|December 24, 2016
Optical coherence tomography imaging in the management of the Argus II retinal prosthesis systemFrancesco Parmeggiani, Katia De Nadai, Angela Piovan, et al.Current Genomics|December 2, 2011
Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-DateFrancesco Parmeggiani, Giovanni Sato, Katia De Nadai, et al.Current Drug Targets|July 10, 2020
Application of Artificial Intelligence in Targeting Retinal DiseasesFrancesco Saverio Sorrentino, Giuseppe Jurman, Katia De Nadai, et al.Pageof 10